Table 1.
Total | No seizures < 2 years poststroke |
Early-onset seizures | p value | 1-week survivors without seizures < 2 years poststroke |
Late-onset seizures | p value | |
---|---|---|---|---|---|---|---|
No. of patients | 444 (100%) | 396 (89.2%) | 16 (3.6%) | 378 (85.1%) | 32 (7.2%) | ||
Male gender | 235 (52.9%) | 212 (53.5%) | 10 (62.5%) | 0.48 | 205 (54.2%) | 13 (40.6%) | 0.14 |
Age (mean) | 70.6 (SD 12.0) | 70.4 (SD 12.1) | 77.3 (SD 5.7) | 0.01 | 70.0 (SD 12.1) | 69.1 (SD 12.5) | 0.83 |
Age (median) | 72.0 (range 26–96) | 71.5 (range 26–96) | 78.0 (range 65–83) | 0.01 | 71 (range 26–94) | 73.5 (range 40–87) | 0.83 |
DM | 95 (21.4%) | 83 (21.0%) | 3 (18.8%) | 0.83 | 78 (20.6%) | 9 (28.1%) | 0.32 |
Hypertension | 203 (45.7%) | 182 (46.0%) | 8 (50.0%) | 0.75 | 175 (46.3%) | 13 (40.6%) | 0.54 |
IHD | 101 (22.7%) | 87 (22.0%) | 6 (37.5%) | 0.15 | 81 (21.4%) | 8 (25.0%) | 0.64 |
Smoking yes | 149 (33.6%) | 133 (33.6%) | 4 (25.0%) | 0.48 | 128 (33.9%) | 12 (37.5%) | 0.68 |
Smoking unk | 38 (8.6%) | 33 (8.3%) | 3 (18.8%) | 0.15 | 31 (8.2%) | 2 (6.3%) | 1.00 |
mRS 1 | 8 (1.8%) | 8 (2.0%) | 0 (0.0%) | 1.00 | 8 (2.1%) | 0 (0.0%) | 1.00 |
mRS 2 | 88 (19.8%) | 87 (22.0%) | 0 (0.0%) | 0.03 | 87 (23.0%) | 1 (3.1%) | 0.01 |
mRS 3 | 118 (26.6%) | 105 (26.5%) | 3 (18.8%) | 0.77 | 105 (27.8%) | 10 (31.3%) | 0.68 |
mRS 4 | 97 (21.8%) | 90 (22.7%) | 3 (18.8%) | 1.00 | 90 (23.8%) | 4 (12.5%) | 0.14 |
mRS 5 | 133 (30.0%) | 106 (26.8%) | 10 (62.5%) | 0.00 | 88 (23.3%) | 17 (53.1%) | 0.00 |
Infarct-type AT | 174 (39.2%) | 147 (37.1%) | 6 (37.5%) | 0.98 | 141 (37.3%) | 21 (65.6%) | 0.00 |
Infarct-type CE | 102 (23.0%) | 88 (22.2%) | 7 (43.8%) | 0.07 | 76 (20.1%) | 7 (21.9%) | 0.81 |
Infarct-type LACI | 168 (37.8%) | 161 (40.7%) | 3 (18.8%) | 0.08 | 161 (42.6%) | 4 (12.5%) | 0.00 |
DM diabetes mellitus, IHD ischemic heart disease, Smoking unk smoking status is unknown, mRS modified Rankin scale, AT atherothrombotic infarct type, CE cardioembolic infarct type, LACI lacunar infarct type